These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6215841)
1. Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs. Martel RR; Klicius J Agents Actions; 1982 Jul; 12(3):295-7. PubMed ID: 6215841 [TBL] [Abstract][Full Text] [Related]
2. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats. Lee D; Dvornik D Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085 [TBL] [Abstract][Full Text] [Related]
4. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. Lee DK; Chau TT; Weichman BM; Wooley PH Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837 [TBL] [Abstract][Full Text] [Related]
6. The effect of the non-steroidal anti-inflammatory drug Etodolac on macrophage migration in vitro and in vivo. Gervais F; Martel RR; Skamene E J Immunopharmacol; 1984; 6(3):205-14. PubMed ID: 6238099 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis. Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897 [TBL] [Abstract][Full Text] [Related]
8. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation. Inoue K; Motonaga A; Dainaka J; Nishimura T; Hashii H; Yamate K; Ueda F; Kimura K Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):457-62. PubMed ID: 7708812 [TBL] [Abstract][Full Text] [Related]
9. Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon 100). Leyck S; Dereu N; Etschenberg E; Ghyczy M; Graf E; Winkelmann J; Parnham MJ Eur J Pharmacol; 1985 Oct; 117(1):35-42. PubMed ID: 4085544 [TBL] [Abstract][Full Text] [Related]
10. Effects of some anti-inflammatory drugs on capillary permeability of the gastric mucosa in the rat. Takagi K; Kawashima K Jpn J Pharmacol; 1969 Sep; 19(3):431-9. PubMed ID: 4390623 [No Abstract] [Full Text] [Related]
11. Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs. Dearden JC; Nicholson RM J Pharm Pharmacol; 1984 Oct; 36(10):713-5. PubMed ID: 6150099 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs. Inoue K; Fujisawa H; Motonaga A; Inoue Y; Kyoi T; Ueda F; Kimura K Biol Pharm Bull; 1994 Dec; 17(12):1577-83. PubMed ID: 7735198 [TBL] [Abstract][Full Text] [Related]
13. Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins. Dvornik D; Lee DK Clin Rheumatol; 1989 Mar; 8 Suppl 1():16-24. PubMed ID: 2525980 [TBL] [Abstract][Full Text] [Related]
14. The topical anti-inflammatory effects of piroxicam in rodents. Larson DL; Lombardino JG Agents Actions; 1980 Jun; 10(3):246-51. PubMed ID: 7405751 [TBL] [Abstract][Full Text] [Related]
15. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928 [TBL] [Abstract][Full Text] [Related]
16. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen. Martel RR; Klicius J; Metcalf G Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845 [TBL] [Abstract][Full Text] [Related]
17. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. Demerson CA; Humber LG; Abraham NA; Schilling G; Martel RR; Pace-Asciak C J Med Chem; 1983 Dec; 26(12):1778-80. PubMed ID: 6227748 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac. Melarange R; Gentry C; Durie M; O'Connell C; Blower PR Dig Dis Sci; 1994 Mar; 39(3):601-8. PubMed ID: 8131699 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam. Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224 [TBL] [Abstract][Full Text] [Related]
20. An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosa. van Eeden A; Schotborgh RH; Tytgat GN Clin Ther; 1990; 12(6):496-502. PubMed ID: 2149673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]